Inventor · disambiguated record
Lin Kang
Also filed as: KANG LIN · KANG LIN-WOO
14 granted patents·26 pending applications·97 citations·filing 2008–2024
91Inventor score
Files withCELULARITY INC14ANTHROGENESIS CORP8NANJING UNIVERSITY OF TECHNOLOGY4HARIRI ROBERT J3ACAD OF MILITARY MEDICAL SCIENCES2
Top patents by PatentIndex Score
40 records- 0196US8263065B2Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsHARIRI ROBERT J·Filed 2008·Granted Sep 11, 2012·31 cites·36 claims
- 0293US8926964B2Methods of generating natural killer cellsHARIRI ROBERT J·Filed 2011·Granted Jan 6, 2015·28 cites·26 claims
- 0390US9464274B2Methods of generating natural killer cellsANTHROGENESIS CORP·Filed 2014·Granted Oct 11, 2016·13 cites·20 claims
- 0489US9216200B2Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsHARIRI ROBERT J·Filed 2012·Granted Dec 22, 2015·5 cites·31 claims
- 0588US9255248B2Method of producing erythrocytes without feeder cellsANTHROGENESIS CORP·Filed 2013·Granted Feb 9, 2016·5 cites·12 claims
- 0684US8586360B2Method of producing erythrocytes without feeder cellsABBOT STEWART·Filed 2010·Granted Nov 19, 2013·4 cites·14 claims
- 0782US11971486B2Method for generating three-dimensional images with superconducting nanowire photon detection arrayNANJING UNIVERSITY OF TECHNOLOGY·Filed 2022·Granted Apr 30, 2024·2 cites·9 claims
- 0877US9200253B1Method of producing erythrocytesHEIDARAN MOHAMMAD A·Filed 2008·Granted Dec 1, 2015·4 cites·11 claims
- 0976US10041043B2Method of producing erythrocytes without feeder cellsCELULARITY INC·Filed 2015·Granted Aug 7, 2018·1 cites·10 claims
- 1075US2022259563A1Methods of generating natural killer cellsCELULARITY INC·Filed 2022·Application pending·0 cites
- 1174US11180731B2Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cellsCELULARITY INC·Filed 2017·Granted Nov 23, 2021·1 cites·18 claims
- 1274US9763983B2Natural killer cells from placentaANTHROGENESIS CORP·Filed 2014·Granted Sep 19, 2017·2 cites·20 claims
- 1370US12360116B2Rapid detection method for abrin toxinACAD OF MILITARY MEDICAL SCIENCES·Filed 2024·Granted Jul 15, 2025·0 cites·6 claims
- 1470US10846324B2Device, method, and user interface for managing and interacting with media contentALIBABA GROUP HOLDING LTD·Filed 2018·Granted Nov 24, 2020·1 cites·20 claims
- 1570US2023142803A1Natural killer cells and ilc3 cells and uses thereofCELULARITY INC·Filed 2022·Application pending·0 cites
- 1668US12282025B1Rapid detection method for ricin toxinACAD OF MILITARY MEDICAL SCIENCES·Filed 2024·Granted Apr 22, 2025·0 cites·6 claims
- 1766US2021032596A1Method of producing erythrocytesCELULARITY INC·Filed 2020·Application pending·0 cites
- 1863US2019330592A1Methods of generating natural killer cellsCELULARITY INC·Filed 2019·Application pending·0 cites
- 1963US2025295776A1Cleavage resistant cd16 constructs and uses thereofCELULARITY INC·Filed 2023·Application pending·0 cites
- 2060US2020246393A1Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibodyCELULARITY INC·Filed 2018·Application pending·0 cites
- 2159US2021121452A1Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compoundsCELULARITY INC·Filed 2020·Application pending·0 cites
- 2257US2021008109A1Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cellsCELGENE CORP·Filed 2020·Application pending·0 cites
- 2356US2017002322A1Methods of generating natural killer cellsANTHROGENESIS CORP·Filed 2016·Application pending·0 cites
- 2456US2017240860A1Method of producing erythrocytesANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 2554US2019093081A1Placenta-derived intermediate natural killer (pink) cells for treatment of glioblastomaCELULARITY INC·Filed 2018·Application pending·0 cites
- 2652US2020330516A1Natural killer cells and uses thereofCELULARITY INC·Filed 2020·Application pending·0 cites
- 2752US2009104164A1Angiogenic cells from human placental perfusateCELGENE CELLULAR THERAPEUTICS·Filed 2008·Application pending·0 cites
- 2852US2022160787A1Placenta derived adherent cells for improved xenoplantationCELULARITY INC·Filed 2020·Application pending·0 cites
- 2951US2010211371A1Collaborative virtual reality system and method for molecular modelingUNIV KONKUK IND COOP CORP·Filed 2009·Application pending·0 cites
- 3049US2022000919A1Placental derived natural killer cells for treatment of coronavirus infectionsCELULARITY INC·Filed 2021·Application pending·0 cites
- 3148US2016287635A1Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 3247US2011280849A1Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compoundsZHANG XIAOKUI·Filed 2011·Application pending·0 cites
- 3347US2023028680A1Expansion of natural killer cells and ilc3 cells with novel aromatic compoundsCELULARITY INC·Filed 2019·Application pending·0 cites
- 3446US2018021378A1Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cellsANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 3545US2022267889A1Fabrication method of silicon nanoneedle array with ultra-high aspect ratioNANJING UNIVERSITY OF TECHNOLOGY·Filed 2020·Application pending·0 cites
- 3643US2023304857A1Design for reducing dark count rate of snspd based on two-wire structureNANJING UNIVERSITY OF TECHNOLOGY·Filed 2021·Application pending·0 cites
- 3742US2018346877A1Natural killer cells and ilc3 cells and uses thereofANTHROGENSIS CORP·Filed 2016·Application pending·0 cites
- 3841US2015225697A1Natural killer cells and uses thereofLAW ERIC·Filed 2013·Application pending·0 cites
- 3939US2018008637A1Natural killer cells and uses thereofANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 4039US2021398345A1Three-dimensional imaging method based on superconducting nanowire photon detection arrayNANJING UNIVERSITY OF TECHNOLOGY·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lin Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →